Clinical and pathological features of three-year survivors of malignant pleural mesothelioma following extrapleural pneumonectomy

European Journal of Cardio-thoracic Surgery

Volumn 40, Issue 2, 2011, Pages 298-303

  Sugarbaker, David J ^a   Wolf, Andrea S ^a   Chirieac, Lucian R ^a   Godleski, John J ^a   Tilleman, Tamara R ^a   Jaklitsch, Michael T ^a   Bueno, Raphael ^a   Richards, William G ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Extrapleural pneumonectomy; Mesothelioma; Staging; Survival

Indexed keywords

ABDOMINAL WALL HERNIA; ACALCULOUS CHOLECYSTITIS; ADULT; AGED; ARTICLE; BRONCHOPLEURAL FISTULA; CANCER ADJUVANT THERAPY; CANCER STAGING; CANCER SURVIVAL; CANCER SURVIVOR; CLOSTRIDIUM DIFFICILE INFECTION; DEEP VEIN THROMBOSIS; DUODENUM ULCER; EXTRAPLEURAL PNEUMONECTOMY; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HEART INFARCTION; HEART RIGHT VENTRICLE FAILURE; HEMOGLOBIN BLOOD LEVEL; HORNER SYNDROME; HUMAN; KIDNEY FAILURE; LENGTH OF STAY; LEUKOCYTE COUNT; LUNG EMBOLISM; LUNG RESECTION; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; MALIGNANT PLEURA MESOTHELIOMA; PLEURA EMPYEMA; PLEURA MESOTHELIOMA; PRIORITY JOURNAL; PROGNOSIS; RECURRENT CANCER; STROKE; SURGICAL INFECTION; SURVIVAL RATE; SURVIVAL TIME; THROMBOCYTE COUNT; TRACHEOSTOMY; URINARY TRACT INFECTION; VOCAL CORD PARALYSIS;

ADOLESCENT; ADULT; AGE FACTORS; AGED; CHEMOTHERAPY, ADJUVANT; EPIDEMIOLOGIC METHODS; FEMALE; HUMANS; MALE; MESOTHELIOMA; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM STAGING; PATIENT SELECTION; PLEURAL NEOPLASMS; PNEUMONECTOMY; PROGNOSIS; RADIOTHERAPY, ADJUVANT; SEX FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 79960266070     PISSN: 10107940     EISSN: 1873734X     Source Type: Journal    
DOI: 10.1016/j.ejcts.2010.12.024     Document Type: Article

References (25)

1. Tsao A.S., Wistuba I., Roth J.A., Kindler H.L. Malignant pleural mesothelioma. J Clin Oncol 2009, 27:2081-2090.
2. Merritt N., Blewett C.J., Miller J.D., Bennett W.F., Young J.E., Urschel J.D. Survival after conservative (palliative) management of pleural malignant mesothelioma. J Surg Oncol 2001, 78:171-174.
3. Vogelzang N.J., Rusthoven J.J., Symanowski J., Denham C., Kaukel E., Ruffie P., Gatzemeier U., Boyer M., Emri S., Manegold C., Niyikiza C., Paoletti P. Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma. J Clin Oncol 2003, 21:2636-2644.
4. Sugarbaker D.J., Flores R.M., Jaklitsch M.T., Richards W.G., Strauss G.M., Corson J.M., DeCamp M.M., Swanson S.J., Bueno R., Lukanich J.M., Baldini E.H., Mentzer S.J. Resection margins, extrapleural nodal status, and cell type determine postoperative long-term survival in trimodality therapy of malignant pleural mesothelioma: results in 183 patients. J Thorac Cardiovasc Surg 1999, 117:54-63. [discussion 63-55].
5. Weder W., Stahel R.A., Bernhard J., Bodis S., Vogt P., Ballabeni P., Lardinois D., Betticher D., Schmid R., Stupp R., Ris H.B., Jermann M., Mingrone W., Roth A.D., Spiliopoulos A. Multicenter trial of neo-adjuvant chemotherapy followed by extrapleural pneumonectomy in malignant pleural mesothelioma. Ann Oncol 2007, 18:1196-1202.
6. de Perrot M., Feld R., Cho B.C., Bezjak A., Anraku M., Burkes R., Roberts H., Tsao M.S., Leighl N., Keshavjee S., Johnston M.R. Trimodality therapy with induction chemotherapy followed by extrapleural pneumonectomy and adjuvant high-dose hemithoracic radiation for malignant pleural mesothelioma. J Clin Oncol 2009, 27:1413-1418.
7. Aziz T., Jilaihawi A., Prakash D. The management of malignant pleural mesothelioma; single centre experience in 10 years. Eur J Cardiothorac Surg 2002, 22:298-305.
8. Richards W.G., Godleski J.J., Yeap B.Y., Corson J.M., Chirieac L.R., Zellos L., Mujoomdar A., Jaklitsch M.T., Bueno R., Sugarbaker D.J. Proposed adjustments to pathologic staging of epithelial malignant pleural mesothelioma based on analysis of 354 cases. Cancer 2010, 116:1510-1517.
9. Richards W.G. Recent advances in mesothelioma staging. Semin Thorac Cardiovasc Surg 2009, 21:105-110.
10. Wolf AS, Richards WG, Tilleman TR, L.R. C, Hurwitz L, Bueno R, Sugarbaker DJ. Characteristics of malignant pleural mesothelioma in women. Ann Thorac Surg 2010;90(3):949-56.
11. Curran D., Sahmoud T., Therasse P., van Meerbeeck J., Postmus P.E., Giaccone G. Prognostic factors in patients with pleural mesothelioma: the European Organization for Research and Treatment of Cancer experience. J Clin Oncol 1998, 16:145-152.
12. Herndon J.E., Green M.R., Chahinian A.P., Corson J.M., Suzuki Y., Vogelzang N.J. Factors predictive of survival among 337 patients with mesothelioma treated between 1984 and 1994 by the cancer and leukemia group B. Chest 1998, 113:723-731.
13. International Union Against Cancer (UICC): TNM classification of tumors. 7th edition. Sobin LH, Gaspodarowicz MK, Wittekind Ch (eds.), Wiley-Blackwell, a John Wiley & Sons Ltd. Publication, West Sussex, UK, 2010.
14. Komaki R., Roth J.A., Walsh G.L., Putnam J.B., Vaporciyan A., Lee J.S., Fossella F.V., Chasen M., Delclos M.E., Cox J.D. Outcome predictors for 143 patients with superior sulcus tumors treated by multidisciplinary approach at the University of Texas M.D. Anderson Cancer Center. Int J Radiat Oncol Biol Phys 2000, 48:347-354.
15. Albain K.S., Rusch V.W., Crowley J.J., Rice T.W., Turrisi A.T., Weick J.K., Lonchyna V.A., Presant C.A., McKenna R.J., Gandara D.R. Concurrent cisplatin/etoposide plus chest radiotherapy followed by surgery for stages IIIA (N2) and IIIB non-small-cell lung cancer: mature results of Southwest Oncology Group phase II study 8805. J Clin Oncol 1995, 13:1880-1892.
16. Malaisrie S.C., Untch B., Aranha G.V., Mohideen N., Hantel A., Pickleman J. Neoadjuvant chemoradiotherapy for locally advanced esophageal cancer: experience at a single institution. Arch Surg 2004, 139:532-538. [discussion 538-9].
17. Bilimoria K.Y., Bentrem D.J., Ko C.Y., Ritchey J., Stewart A.K., Winchester D.P., Talamonti M.S. Validation of the 6th edition AJCC pancreatic cancer staging system: report from the National Cancer Database. Cancer 2007, 110:738-744.
18. Sugarbaker D.J., Jaklitsch M.T., Bueno R., Richards W., Lukanich J., Mentzer S.J., Colson Y., Linden P., Chang M., Capalbo L., Oldread E., Neragi-Miandoab S., Swanson S.J., Zellos L.S. Prevention, early detection, and management of complications after 328 consecutive extrapleural pneumonectomies. J Thorac Cardiovasc Surg 2004, 128:138-146.
19. Gordon G.J., Dong L., Yeap B.Y., Richards W.G., Glickman J.N., Edenfield H., Mani M., Colquitt R., Maulik G., Van Oss B., Sugarbaker D.J., Bueno R. Four-gene expression ratio test for survival in patients undergoing surgery for mesothelioma. J Natl Cancer Inst 2009, 101:678-686.
20. Sugarbaker D.J., Richards W.G., Gordon G.J., Dong L., De Rienzo A., Maulik G., Glickman J.N., Chirieac L.R., Hartman M.L., Taillon B.E., Du L., Bouffard P., Kingsmore S.F., Miller N.A., Farmer A.D., Jensen R.V., Gullans S.R., Bueno R. Transcriptome sequencing of malignant pleural mesothelioma tumors. Proc Natl Acad Sci U S A 2008, 105:3521-3526.
21. Bueno R., De Rienzo A., Dong L., Gordon G.J., Hercus C.F., Richards W.G., Jensen R.V., Anwar A., Maulik G., Chirieac L.R., Ho K.F., Taillon B.E., Turcotte C.L., Hercus R.G., Gullans S.R., Sugarbaker D.J. Second generation sequencing of the mesothelioma tumor genome. PLoS One 2010, 5:e10612.
22. Sugarbaker D.J. Macroscopic complete resection: the goal of primary surgery in multimodality therapy for pleural mesothelioma. J Thorac Oncol 2006, 1:175-176.
23. Sugarbaker D.J., Wolf A.S. Surgery for malignant pleural mesothelioma. Expert Rev Respir Med 2010, 4:363-372.
24. Pinton G., Brunelli E., Murer B., Puntoni R., Puntoni M., Fennell D.A., Gaudino G., Mutti L., Moro L. Estrogen receptor-beta affects the prognosis of human malignant mesothelioma. Cancer Res 2009, 69:4598-4604.
25. Flores R.M. Surgical options in malignant pleural mesothelioma: extrapleural pneumonectomy or pleurectomy/decortication. Semin Thorac Cardiovasc Surg. 2009, 21(2):149-153.